BioNTech SE (BNTX)
NASDAQ:BNTX

BioNTech SE (BNTX) Stock Price & Analysis

3,885 Followers

BNTX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$94.68 - $188.99
Previous Close$96.59
Volume820.86K
Average Volume (3M)730.76K
Market Cap
$23.47B
Enterprise Value$9.60B
Total Cash (Recent Filing)$13.88B
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)5.3
Beta0.62
Nov 06, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)18.33
Shares Outstanding240,993,998
10 Day Avg. Volume744,935
30 Day Avg. Volume730,762
Standard Deviation0.25
R-Squared0.00282
Alpha0.07
Financial Highlights & Ratios
Price to Book (P/B)1.14
Price to Sales (P/S)1.34
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.00
Enterprise Value/Gross Profit0.67
Enterprise Value/Ebitda1.30
Forecast
Price Target Upside44.95% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

BNTX FAQ

What was BioNTech SE’s price range in the past 12 months?
BioNTech SE lowest stock price was $94.68 and its highest was $188.99 in the past 12 months.
    What is BioNTech SE’s market cap?
    Currently, no data Available
    When is BioNTech SE’s upcoming earnings report date?
    BioNTech SE’s upcoming earnings report date is Nov 06, 2023 which is in 19 days.
      How were BioNTech SE’s earnings last quarter?
      BioNTech SE released its earnings results on Aug 07, 2023. The company reported -$0.831 earnings per share for the quarter, beating the consensus estimate of -$0.877 by $0.045.
        Is BioNTech SE overvalued?
        According to Wall Street analysts BioNTech SE’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does BioNTech SE pay dividends?
          BioNTech SE pays a Notavailable dividend of $1.53 which represents an annual dividend yield of N/A. See more information on BioNTech SE dividends here
            What is BioNTech SE’s EPS estimate?
            BioNTech SE’s EPS estimate is -$0.11.
              How many shares outstanding does BioNTech SE have?
              BioNTech SE has 243,019,210 shares outstanding.
                What happened to BioNTech SE’s price movement after its last earnings report?
                BioNTech SE reported an EPS of -$0.831 in its last earnings report, beating expectations of -$0.877. Following the earnings report the stock price went down -7.494%.
                  Which hedge fund is a major shareholder of BioNTech SE?
                  Among the largest hedge funds holding BioNTech SE’s share is PRIMECAP Management Co. It holds BioNTech SE’s shares valued at 503M.

                    ---

                    BioNTech SE Stock Smart Score

                    The BioNTech SE stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    BioNTech SE

                    BioNTech SE is a Germany-based biotechnology company that develops and manufactures immunotherapies for cancer, infectious diseases, allergies and autoimmune disorders.

                    ---

                    Top 5 ETFs holding BNTX

                    Name
                    Market Value
                    Smart Score
                    Fidelity Nasdaq Composite Index ETF
                    $2.34M
                    8
                    Xtrackers S&P 500 Swap UCITS ETF 5C-EUR Hedged
                    $1.75M
                    8
                    Xtrackers S&P 500 Swap UCITS ETF
                    $1.75M
                    8
                    Invesco RAFI Strategic US ETF
                    $445.28K
                    8
                    HCM Defender 100 Index ETF
                    $174.25K
                    8
                    Up to five ETFs with an Outperform Smart Score that hold BNTX. The ETFs are listed according to market value of BNTX within the ETF

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Moderna
                    Novavax
                    Pfizer
                    GlaxoSmithKline

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis